146 related articles for article (PubMed ID: 22612305)
1. Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes.
Mir-Bonafé JM; Román-Curto C; Santos-Briz A; Cañueto J; Fernández-López E; Unamuno P
J Cutan Pathol; 2012 Jul; 39(7):707-11. PubMed ID: 22612305
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
Katagiri D; Hinoshita F
CEN Case Rep; 2018 Nov; 7(2):217-220. PubMed ID: 29766468
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-induced thrombotic microangiopathy.
Richmond J; Gilbar P; Abro E
Intern Med J; 2013 Nov; 43(11):1240-2. PubMed ID: 24237646
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.
Leal F; Macedo LT; Carvalheira JB
J Chemother; 2014 Jun; 26(3):169-72. PubMed ID: 24091354
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
Flombaum CD; Mouradian JA; Casper ES; Erlandson RA; Benedetti F
Am J Kidney Dis; 1999 Mar; 33(3):555-62. PubMed ID: 10070921
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic Microangiopathy in a Patient Treated With Gemcitabine.
Nanjappa S; Singh V; Uttamchandani S; Pabbathi S
Cancer Control; 2017 Jan; 24(1):54-56. PubMed ID: 28178713
[TBL] [Abstract][Full Text] [Related]
7. [Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?].
Charmetant X; Jolivot A; Fournier T; Puthet JC; Cassier P; Lemoine S; Juillard L
Nephrol Ther; 2017 Jun; 13(4):251-254. PubMed ID: 28499586
[TBL] [Abstract][Full Text] [Related]
8. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
[TBL] [Abstract][Full Text] [Related]
9. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
Burns ST; Damon L; Akagi N; Laszik Z; Ko AH
Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.
Daviet F; Rouby F; Poullin P; Moussi-Francès J; Sallée M; Burtey S; Mancini J; Duffaud F; Sabatier R; Pourroy B; Grandvuillemin A; Grange S; Frémeaux-Bacchi V; Coppo P; Micallef J; Jourde-Chiche N
Br J Clin Pharmacol; 2019 Feb; 85(2):403-412. PubMed ID: 30394581
[TBL] [Abstract][Full Text] [Related]
11. Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis.
Thomas JG; Sethi S; Norby SM
Am J Kidney Dis; 2011 May; 57(5):799-802. PubMed ID: 21411201
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report].
Rogier T; Gerfaud-Valentin M; Pouteil-Noble C; Taleb A; Guillet M; Noel A; Broussolle C; Sève P
Rev Med Interne; 2016 Oct; 37(10):701-704. PubMed ID: 26833144
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic-uremic syndrome associated with gemcitabine use: report of one case].
Vega J; Parodi C; Méndez GP; Goecke H
Rev Med Chil; 2013 Jun; 141(6):797-802. PubMed ID: 24121585
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
15. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T
BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents and thrombotic microangiopathy.
Garcia G; Atallah JP
J Oncol Pharm Pract; 2017 Mar; 23(2):135-142. PubMed ID: 26854265
[TBL] [Abstract][Full Text] [Related]
17. [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature].
Dilhuydy MS; Delclaux C; Pariente A; De Precigout V; Aparicio M
Rev Med Interne; 2002 Feb; 23(2):189-92. PubMed ID: 11876063
[TBL] [Abstract][Full Text] [Related]
18. [Gemcitabine-induced thrombotic microangiopathy].
Teixeira L; Debourdeau P; Zammit C; Estival JL; Pavic M; Colle B
Presse Med; 2002 Apr; 31(16):740-2. PubMed ID: 12148351
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.
Lhotta K; Kühr T; Rumpelt HJ; Wöll E; Thaler J; König P
Am J Nephrol; 1999; 19(5):590-3. PubMed ID: 10575189
[TBL] [Abstract][Full Text] [Related]
20. [Thrombotic microangiopathy under an effective treatment with gemcitabine].
Finkenwirth P; Schick D; Horger MS; Fend F; Lauer UM; Gregor M; Bitzer M
Z Gastroenterol; 2009 Mar; 47(3):288-91. PubMed ID: 19280543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
